Prevalence of dyslipidemia and its association with disease activity in patients with rheumatoid arthritis attending Rizgary Teaching Hospital in Erbil City

Shnow Burhan Hameed; Niaz J. Al-Barzinjy

doi:10.15218/zjms.2017.034

Authors

Shnow Burhan Hameed Erbil Directorate of Health, Erbil, Iraq.
Niaz J. Al-Barzinjy Department of internal Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2017.034

Keywords:

Rheumatoid arthritis, Dyslipidemia, Disease activity

Abstract

Background and objective: This study aimed to measure the prevalence of dyslipidemia in patients with rheumatoid arthritis compared with healthy control people and find out the correlation between dyslipidemia and disease activity.

Methods: A prospective case-control was done. A total of 100 female patients with rheumatoid arthritis were included in the study. This study was conducted at the Rheumatology Out-patient Clinic in Rizgary Teaching Hospital, Erbil City over seven months from April 2013 to October 2013. Patients who fulfilling the 1987 revised American College of Rheumatology and 2010 American College of Rheumatology/European League against rheumatism classification criteria for rheumatoid arthritis and 100 healthy female age-matched controls with the mean age for both groups being 45. Fasting lipid profiles of cases and controls were estimated after an overnight fasting of 12 hours. Association between lipid profile and disease activity using disease activity score DAS 28, inflammatory markers (CRP and ESR) was also determined.

Results: Rheumatoid arthritis patients showed a higher prevalence of associated dyslipidemia (47%) in comparison to control (5%), P = 0.004. There was a significant reduction in serum high density lipoproteins (P = 0.04), with significant elevation of serum total cholesterol, triglyceride, low density lipoprotein and very low density lipoprotein (P = 0.001, 0.004, 0.04 and 0.05, respectively) in comparison to controls. There was a significant relation between disease activity score 28 and serum high density lipoproteins (P <0.001) and there was a significant relation between ESR and triglyceride (P = 0.05).

Conclusion: is frequent among the patients with rheumatoid arthritis and highly associated with active rheumatoid arthritis. Serum high density lipoproteins significantly reduced while other parameters of lipid profiles significantly increased in comparisons to control.

Metrics

Metrics Loading ...

References

Doherty M, Lanyon P, Ralston SH. Rheumatoid arthritis. Boon NA; College NR; Walker BR; Hunter JAA. Davidson’s principles and practice of medicine . Churchill Livingstone; 2006. P. 1101-6.

Taysi S, Polat F, Gul M, Sari RA,Bakan E. lipid peroxidation, some extracellar antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002;21: 200-4.

Heimick CG, Flson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimate of the prevalence of arthritis and other rheumatic conditions in the US. Part I. Arthritis Rheum 2008; 58(1):15-25.

National Institute of Arthritis and Musculoskeletal and Skin Disease. "Handout on health: Rheumatoid Arthritis". April 2009.Retrieved 2013-03-26.

Tehlirian CV, Bathon JM. Rheumatoid arthritis. Klippel JH ,Stone JH,Crofford LJ,White PH. Primer on Rheumatic diseases ,NY,USA.Springer Science+Business Media 2008; P. 114-21.

Symmons D, Barrett E, Bankhead C. The occurrence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33:735-9.

Waldenburger JM, Firestein GS. Rheumatoid arthritis. Klippel JH, Stone JH, Crofford LJ, and White PH, . Primer on the Rheumatic Disease, New York, USA: Springer Science and Business Media; 2008. P.122- 32.

Ebringer A, Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Dev Immunol 2006; 13(1): 41–8.

Dieppe P. Osteoarthritis, in Primer on the Rheumatic Diseases. 2008, Springer. p. 114.

Jacoby R, Cosh J, Jayson M. early stages , and prognosis of rheumatoid arthritis : a clinical study with 100 patients with 11 years of follow –up. Br Med J 1973;2:96-100.

Ralston SH, Doherty M. Rheumatoid arthritis. In: Colledge NR; Walker BR; Ralston 11.S.H.(editors). Davidson’s principles and practice of medicine, 21st ed. Churchill Livingstone; 2010. P. 1088-92.

Spellman CW. Strategies for optimizing lipid treatment outcomes. J Am Osteopath Assoc 2003; 103:S12-5.

Isomaki Ha, Mutru O, Koota K, Death rate and cause of death in patients with Rheumatoid Arthritis. Scand J Rheumatol 1975; 4:205-8.

Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Causes of death in rheumatoid arthritis. Br J Rheumatol 1984 23; 92-9.

Rossner S. Further studies on serum lipoproteins in connective tissue disease. Atherosclerosis 1978:31:93-9.

Leong KH, Koh ET, Feng PH , Boey ML. Lipid profiles in patients with systemic lupus erythematosus.J Rheumatol 1994;21: 1264-7.

Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, RogerVL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arth & Rheum 2005; 52(2):402-411.

Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003; 30: 36–40.

WHO Expert Committee. Physical status: the use and interpretation of anthropometry. WHO Tech Rep Ser 1995; 854:424–38.

Alamanos Y, Voulgari PV, Doros AA. Incidence and prevalence of rheumatoid arthritis based on 1987 American College of Rheumatology criteria: A systematic review. Semin Arthritis Rheum 2006; 36(3): 182-8.

Abdul-Qahar ZH, Al-Osami MH, Al-Asady. Prevalence of Metabolic Syndrome in Iraqi Patients with Rheumatoid Arthritis. IOSR Journal of Dental and Medical Science (IOSR-JDMS). 2013;11(1):69-72.

Kotzin BL: The role f B cells in the pathogenesis of Rheumatoid Arthritis. J Rheumatol Suppl 2005; 73:14-7.

Nisar A, Rasheed U, Aziz W,Farooqi AZ. Prevalence of Dyslipidemia in Autoimmune Rheumatic Diseases.Journal of the college of Physicians and Surgeons Pakistan 2012;22 (4):235-9.

Zrour SH, Neffeti FH, Sakly N , Saoussen H,Korbaa Y, et al. lipid profile in Tunisian patients with Rheumatoid Arthritis. 2011; 30 (10):1325-31.

Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2008; 38:372-81.

Manjunatha Goud BK, Sarsina Devi O, Bhavana N, Devaki RN, Deepa K , Niveditha S. Nutritional Antioxidants and lipid profile in newly diagnosed Rheumatoid arthritis patients. The International Medical Journal Malasysia IMJM 2012; 11 (1):5-8.

Vinapamula KS, Manohar SM, Bitla AR, Kanduri R, Bhattaram SK, Pemmaraju SR. Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population.Indian Journal of Rheumatology 2013; 8 (4):155-60.

Bahlas S, Ahmed MM. Lipid levels and association with disease activity in RA and SLE in Saudi Arabia 2013; 11 (7)1-6.

Ameer KA, Alosami MH, Salih ES. Comparative study of predicting the risk of cardiovascular diseases in active RA Iraqi patients by traditional and non traditional methods. GJBB 2013; 2(4):522-6.

Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment: a prospective, controlled study. Arthritis Res Ther 2006; 8:R82.

Dursunoglu D, Evrengul H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatology international 2005; 25: 241-5.

Borman P, Seçkin ü , Yücel M. dyslipidemia in patients with RA and Osteoarthritis: Physical medicine 1999;2(3) 5-9.

Al-Zaidi GH, Abdulsamad T. Serum lipids in patients with active rheumatoid arthritis and its relation to drug therapy: J Fac Med Baghdad 2005; 47(1): 35-9.